News from the Institute
Prof. Stefan Müller is appointed W2 professor in biochemistry at IBCII and will be an independant group leader for SUMO signaling group.
... (read more)
Dr. Christian Behrends from Harvard Medical School in Boston will join IBCII as an independant group leader. He will establish the Autophagy signaling group.
... (read more)
PROXIDRUGS researchers and collaborating universities have discovered a way to prevent harmful TDP-43 aggregates in cells under stress by redirecting the protein to the cell’s own repair system—offering promising new strategies for treating ALS and other neurodegenerative diseases.
... (read more)